SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?


To: Marc Kahn who wrote (73)11/7/1997 8:19:00 PM
From: Michael C. Woodward  Respond to of 534
 
Good feedback, Marc.

Maybe Bioject's subsidiary, Bioject JV Subsidiary Inc., will use space to manufacture the ambulatory monitoring system. The system is expected to include a patch-like sensor coupled with a wrist watch-type monitoring device to measure glucose levels of diabetics. The subsidiary is a joint venture 80.1% owned by Bioject and 19.9% by Elan.